Histone deacetylase inhibitors dysregulate DNA repair proteins and antagonize metastasis-associated processes

PURPOSE: We set out to determine whether clinically tested epigenetic drugs against class I histone deacetylases (HDACs) affect hallmarks of the metastatic process. METHODS: We treated permanent and primary renal, lung, and breast cancer cells with the class I histone deacetylase inhibitors (HDACi)...

全面介紹

Na minha lista:
書目詳細資料
發表在:J Cancer Res Clin Oncol
Main Authors: Kiweler, Nicole, Wünsch, Désirée, Wirth, Matthias, Mahendrarajah, Nisintha, Schneider, Günter, Stauber, Roland H., Brenner, Walburgis, Butter, Falk, Krämer, Oliver H.
格式: Artigo
語言:Inglês
出版: Springer Berlin Heidelberg 2020
主題:
Original Article – Cancer Research
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC6985217/
https://ncbi.nlm.nih.gov/pubmed/31932908
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00432-019-03118-4
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍